Discontinued — last reported Q4 '25
Health Care — Cost incurred
Procter & Gamble Health Care — Cost incurred remained flat by 0.0% to $7.5M in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 9.1%, from $8.25M to $7.5M. Over 3 years (FY 2022 to FY 2025), Health Care — Cost incurred shows relatively stable performance with a -2.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase may signal higher investment in segment-specific initiatives or regulatory compliance, while a decrease could indicate improved cost management or reduced project activity.
Detailed definition
This metric represents the specific operational or project-based costs directly attributed to the Health Care segment th...
Peer comparison
Peers in the consumer health or pharmaceutical space report similar line items as 'segment-specific operating expenses' or 'direct segment R&D/compliance costs' to isolate business-unit performance.
pg_segment_health_care_cost_incurredHistorical Data
| FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|
| Value | $32M | $28M | $33M | $30M |
| YoY Change | — | -12.5% | +17.9% | -9.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Procter & Gamble's health care — cost incurred?
- Procter & Gamble (PG) reported health care — cost incurred of $7.5M in Q2 2025.
- How has Procter & Gamble's health care — cost incurred changed year-over-year?
- Procter & Gamble's health care — cost incurred decreased by 9.1% year-over-year, from $8.25M to $7.5M.
- What is the long-term trend for Procter & Gamble's health care — cost incurred?
- Over 3 years (2022 to 2025), Procter & Gamble's health care — cost incurred has grown at a -2.1% compound annual growth rate (CAGR), from $32M to $30M.
- What does health care — cost incurred mean?
- The total specific operational costs directly charged to the Health Care business segment.